For: | Andrade RJ, Robles M, Fernández-Castañer A, López-Ortega S, López-Vega MC, Lucena MI. Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists. World J Gastroenterol 2007; 13(3): 329-340 [PMID: 17230599 DOI: 10.3748/wjg.v13.i3.329] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i3/329.htm |
Number | Citing Articles |
1 |
Hassan Farghali, Mighty Kgalalelo Kemelo, Nikolina Kutinová Canová. Sirtuin Biology in Medicine. 2021; : 295 doi: 10.1016/B978-0-12-814118-2.00014-8
|
2 |
Alejandra Cano Paniagua, Pedro Amariles. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. 2018; doi: 10.5772/intechopen.72005
|
3 |
Mohammed Muqeet Adnan, Muhammad Khan, Syed Hashmi, Muhammad Hamza, Sufyan AbdulMujeeb, Syed Amer. Black Cohosh and Liver Toxicity: Is There a Relationship?. Case Reports in Gastrointestinal Medicine 2014; 2014: 1 doi: 10.1155/2014/860614
|
4 |
Chuanxia Yao, Yiwen Wang, DanDan Gong, Tian Feng, Yaqiong Zhang, Chunhui Wang, Maorong Wang, Jin Zhu. Anti-TLR4 IgG2 Prevents Acetaminophen-induced Acute Liver
Injury through the Toll-like Receptor 4/MAPKs Signaling Pathway
in Mice. Current Molecular Medicine 2023; 23(5): 453 doi: 10.2174/1566524022666220516141728
|
5 |
Thiago S. Cruz, Priscila A. Faria, Débora P. Santana, Juliana C. Ferreira, Vitor Oliveira, Otaciro R. Nascimento, Giselle Cerchiaro, Carlos Curti, Iseli L. Nantes, Tiago Rodrigues. On the mechanisms of phenothiazine-induced mitochondrial permeability transition: Thiol oxidation, strict Ca2+ dependence, and cyt c release. Biochemical Pharmacology 2010; 80(8): 1284 doi: 10.1016/j.bcp.2010.06.052
|
6 |
Maria Giovanna Minissale, Lidya Giannitrapani, Adele Capitano, Ilaria Morreale, Anna Licata. A questionable diagnosis in a woman with drowsiness. Internal and Emergency Medicine 2021; 16(4): 1017 doi: 10.1007/s11739-019-02256-4
|
7 |
Seung-Gul Kang, Byung-Mun Yoon, Young-Min Park. Mirtazapine-Induced Hepatocellular-Type Liver Injury. Annals of Pharmacotherapy 2011; 45(6): 825 doi: 10.1345/aph.1Q078
|
8 |
Mária Szántová, Jozef Sedlačko, Martina Jakabovičová. Drug and herbal hepatotoxicity: an overview of clinical classifications. Vnitřní lékařství 2018; 64(4): 384 doi: 10.36290/vnl.2018.057
|
9 |
Edgar Rincón-Villamizar, Guillermo Restrepo. Rules relating hepatotoxicity with structural attributes of drugs. Toxicological & Environmental Chemistry 2014; 96(4): 594 doi: 10.1080/02772248.2014.961458
|
10 |
B.K. Sołtysik, A. Cieślak-Skubel, E. Piechocka-Wochniak, R. Błaszczak, T. Kostka. A case of rhabdomyolysis and liver injury induced by promazine hydrochloride. European Geriatric Medicine 2015; 6(6): 611 doi: 10.1016/j.eurger.2015.02.002
|
11 |
Jair Francisco de Santana Graim, Gaspar de Jesus Lopes Filho, Marcus Vinicius Henriques Brito, Lia Tavares de Moura Brasil Matos. Histologic evaluation of rats' liver after Croton cajucara Benth (sacaca) administration. Acta Cirurgica Brasileira 2008; 23(2): 130 doi: 10.1590/S0102-86502008000200004
|
12 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2007; 16(9) doi: 10.1002/pds.1370
|
13 |
Lvfeng Yao, Jianzhong Zhang, Jie Jin, Hongbin Li, Lei Li, Xian Han, Hafiz Khuram Raza, Xiaoyun Li, Yimin Mao. An analysis of the efficacy and safety of compound glycyrrhizin injections in the treatment of drug-induced liver injury using a nationwide database. International Journal of Clinical Pharmacy 2022; 44(3): 731 doi: 10.1007/s11096-022-01402-x
|
14 |
T. R. Mirsaev. Experimental study of hepatoprotective activity of hydroxymethyluracil. Bulletin of Experimental Biology and Medicine 2007; 143(5): 575 doi: 10.1007/s10517-007-0183-y
|
15 |
Pietro Gareri, Rosa P. Cerra, Laura Greco, Tania Falbo, Carlo Torchia, Giuseppe Coppolino, Alberto Castagna, Giovanni Ruotolo. Parenteral amiodarone-induced hepatoxicity: when being earnest is an added value. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2019; 178(7-8) doi: 10.23736/S0393-3660.18.03868-8
|
16 |
E. Kutoh. Probable linagliptin-induced liver toxicity: A case report. Diabetes & Metabolism 2014; 40(1): 82 doi: 10.1016/j.diabet.2013.09.009
|
17 |
Geok Soon Lim, Joseph S. Chang, Zhang Lei, Ruige Wu, Zhiping Wang, Kemi Cui, Stephen Wong. A lab-on-a-chip system integrating tissue sample preparation and multiplex RT-qPCR for gene expression analysis in point-of-care hepatotoxicity assessment. Lab on a Chip 2015; 15(20): 4032 doi: 10.1039/C5LC00798D
|
18 |
Muaed Jamal Alomar. Factors affecting the development of adverse drug reactions (Review article). Saudi Pharmaceutical Journal 2014; 22(2): 83 doi: 10.1016/j.jsps.2013.02.003
|
19 |
Dandapantula N Sarma, Marilyn L Barrett, Mary L Chavez, Paula Gardiner, Richard Ko, Gail B Mahady, Robin J Marles, Linda S Pellicore, Gabriel I Giancaspro, Tieraona Low Dog. Safety of Green Tea Extracts. Drug Safety 2008; 31(6): 469 doi: 10.2165/00002018-200831060-00003
|
20 |
|
21 |
Alejandra Cano-Paniagua, Pedro Amariles, Nancy Angulo, Margarita Restrepo-Garay. Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment. Annals of Hepatology 2019; 18(3): 501 doi: 10.1016/j.aohep.2018.11.008
|
22 |
David N Assis, Victor J Navarro. Human drug hepatotoxicity: a contemporary clinical perspective. Expert Opinion on Drug Metabolism & Toxicology 2009; 5(5): 463 doi: 10.1517/17425250902927386
|
23 |
Martin Munz, Hans Grummich, Josef Birkmann, Martin Wilhelm, Ulrike Holzgrabe, Fritz Sörgel. Severe Drug-Induced Liver Injury as an Adverse Drug Event of Antibiotics: A Case Report and Review of the Literature. Chemotherapy 2017; 62(6): 367 doi: 10.1159/000480399
|
24 |
G. Alonso Claudio, R. Merchn Rodrguez, E. Santos Corraliza, A. Fuertes Martn. Da?o hep?tico inducido por medicamentos y t?xicos (excluido el alcohol). Medicine - Programa de Formaci?n M?dica Continuada Acreditado 2008; 10(10): 619 doi: 10.1016/S0211-3449(08)73126-6
|
25 |
Hendyelle Rodrigues Ferreira e Silva, Ana Cláudia de Brito Passos, Maria Augusta Drago Ferreira. Hepatotoxicidade causada após uso oral de Aloe vera (L.) Burm. f. (Asphodelaceae). Revista Fitos 2024; 18(1): e1567 doi: 10.32712/2446-4775.2024.1567
|
26 |
Naresh P Shanmugam, Anil Dhawan. Critical Care in Acute Liver Failure. 2013; : 142 doi: 10.2217/ebo.12.397
|
27 |
Françoise Van Bambeke, Paul M. Tulkens. Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin. Drug Safety 2009; 32(5): 359 doi: 10.2165/00002018-200932050-00001
|
28 |
Catherine J Cone, Amy M Bachyrycz, Glen H Murata. Hepatotoxicity Associated with Metformin Therapy in Treatment of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease. Annals of Pharmacotherapy 2010; 44(10): 1655 doi: 10.1345/aph.1P099
|
29 |
Aida Ortega-Alonso, Camilla Stephens, M. Lucena, Raúl Andrade. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. International Journal of Molecular Sciences 2016; 17(5): 714 doi: 10.3390/ijms17050714
|
30 |
Timothy Danboyi, Abdulazeez Jimoh, Evelyn Hassan-Danboyi, Abdul Wahab Alhassan, Augustine Banlibo Dubo. Dexamethasone-Induced Derangement in Some Liver Function Parameters. Nigerian Journal of Experimental and Clinical Biosciences 2022; 10(3): 74 doi: 10.4103/njecp.njecp_11_22
|
31 |
M. M. Miljkovic, S. Dobric, V. Dragojevic-Simic. Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity. Journal of Clinical Pharmacy and Therapeutics 2012; 37(2): 196 doi: 10.1111/j.1365-2710.2011.01282.x
|
32 |
|
33 |
Paweł Piwowarczyk, Paweł Kutnik, Beata Potręć-Studzińska, Justyna Sysiak-Sławecka, Elżbieta Rypulak, Michał Borys, Mirosław Czczuwar. Hemoadsorption in isolated conjugated hyperbilirubinemia after extracorporeal membrane oxygenation support. Cholestasis of sepsis: A case report and review of the literature on differential causes of jaundice in ICU patient. The International Journal of Artificial Organs 2019; 42(5): 263 doi: 10.1177/0391398819834012
|
34 |
H. Karl Greenblatt, David J. Greenblatt. Liver injury associated with ketoconazole: Review of the published evidence. The Journal of Clinical Pharmacology 2014; 54(12): 1321 doi: 10.1002/jcph.400
|
35 |
Yves Lula Ntamba, Hypolite Muhindo Mavoko, Marion Kalabuanga, Blaise Fungula, Pierre-Michel Ntamabyaliro Nsengi, Gaston Tona Lutete, Raquel Inocencio da Luz, Jean-Pierre Van geertruyden, Pascal Lutumba, Andres Guillermo Lescano. Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo. PLOS ONE 2019; 14(9): e0222379 doi: 10.1371/journal.pone.0222379
|
36 |
A. H. Osman, M. F. El Miniawy Hala, A. M. Zakia, A. M. Mahmoud, M. H. Mohamed, A. M. Khattab, M. A. Zaki Ewiss. RABBIT’S HEALTH AND ENVIRONMENTAL IMPACTS OF EXPLOITATION TREATED BIODEGRADABLE POLLUTION WATER BY JOHKASOU SYSTEM. Taiwan Veterinary Journal 2018; 44(03): 125 doi: 10.1142/S1682648517500135
|
37 |
Anna Licata. Adverse drug reactions and organ damage: The liver. European Journal of Internal Medicine 2016; 28: 9 doi: 10.1016/j.ejim.2015.12.017
|
38 |
J. Crespo, M. Lpez Lpez, M.T. Arias Loste. Hepatitis. Concepto. Clasificaci?n etiol?gica y patocr?nica. Mecanismos patog?nicos de da?o hep?tico. Historia natural. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 2008; 10(9): 541 doi: 10.1016/S0211-3449(08)73112-6
|
39 |
K. Stavrakeva, M. Popova, M. Esad, E. Apostolova, V. Kokova, M. Bacelova, A. Alakidi, A. Bivolarska. Drug-Induced Liver Toxicity. Acta Medica Bulgarica 2024; 51(4): 77 doi: 10.2478/amb-2024-0083
|
40 |
Miren García-Cortés, Camilla Stephens, M. Isabel Lucena, Alejandra Fernández-Castañer, Raúl J. Andrade. Causality assessment methods in drug induced liver injury: Strengths and weaknesses. Journal of Hepatology 2011; 55(3): 683 doi: 10.1016/j.jhep.2011.02.007
|
41 |
M. Sistanizad, G. M. Peterson. Drug-induced liver injury in the Australian setting. Journal of Clinical Pharmacy and Therapeutics 2013; 38(2): 115 doi: 10.1111/jcpt.12039
|
42 |
Alberto Fernandez-Atutxa, Mercedes Vergara, Montserrat Gil, Blai Dalmau, Mireia Miquel, Jordi Sanchez-Delgado, Meritxell Casas. Hepatotoxicidad de rizatriptán. Descripción de un caso clínico. Gastroenterología y Hepatología 2013; 36(4): 261 doi: 10.1016/j.gastrohep.2012.07.010
|
43 |
Ji Min Han, Jeong Yee, Soyeon Cho, Min Kyoung Kim, Jin Young Moon, Dasom Jung, Jung Sun Kim, Hye Sun Gwak. A Risk Scoring System Utilizing Machine Learning Methods for Hepatotoxicity Prediction One Year After the Initiation of Tyrosine Kinase Inhibitors. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.790343
|
44 |
Laura Crespo Pérez, Víctor Moreira Vicente, Ana Cano Ruiz, José María Gobernado Serrano, Natalia Cobo Ibañez, José María Milicua Salamero. Síndrome de hipersensibilidad a anticomiciales: una entidad para recordar. Gastroenterología y Hepatología 2009; 32(10): 687 doi: 10.1016/j.gastrohep.2009.06.008
|
45 |
Yasmin A. Abd-Elnaby, Ibrahim E. ElSayed, Mabrouk A. AbdEldaim, Eman A. Badr, Mona M. Abdelhafez, Ibrahim Elmadbouh. Anti-inflammatory and antioxidant effect of Moringa oleifera against bisphenol-A-induced hepatotoxicity. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00219-7
|
46 |
Fabio Firenzuoli, Luigi Gori, Paolo Roberti di Sarsina. Black Cohosh Hepatic Safety: Follow‐up of 107 Patients Consuming a Special Cimicifuga racemosa rhizome Herbal Extract and Review of Literature. Evidence-Based Complementary and Alternative Medicine 2011; 2011(1) doi: 10.1093/ecam/821392
|
47 |
Pablo Solís-Muñoz, Juan Carlos López, William Bernal, Christopher Willars, Ana Verma, Michael A. Heneghan, Julia Wendon, Georg Auzinger. Voriconazole hepatotoxicity in severe liver dysfunction. Journal of Infection 2013; 66(1): 80 doi: 10.1016/j.jinf.2012.09.011
|
48 |
F Hammann, H Gutmann, N Vogt, C Helma, J Drewe. Prediction of Adverse Drug Reactions Using Decision Tree Modeling. Clinical Pharmacology & Therapeutics 2010; 88(1): 52 doi: 10.1038/clpt.2009.248
|
49 |
Vishal Jain, C. S. Pitchumoni. Gastrointestinal Side Effects of Prescription Medications in the Older Adult. Journal of Clinical Gastroenterology 2009; 43(2): 103 doi: 10.1097/MCG.0b013e31818f9227
|
50 |
Brahm Javier, Brahm Magdalena, Segovia Roberto, Latorre Ricardo, Zapata Rodrigo, Poniachik Jaime, Buckel Erwin, Contreras Luis. Acute and fulminant hepatitis induced by flutamide: Case series report and review of the literature. Annals of Hepatology 2011; 10(1): 93 doi: 10.1016/S1665-2681(19)31595-9
|
51 |
Andrew Slack, Navjoyt Ladher, Julia Wendon. Liver Anesthesiology and Critical Care Medicine. 2012; : 21 doi: 10.1007/978-1-4614-5167-9_2
|
52 |
Sung Gyu Im, Sun Hong Yoo, Dong Ok Jeon, Hyo Jin Cho, Jin Young Choi, Soya Paik, Young Min Park. Chelidonium majus-Induced Acute Hepatitis. The Ewha Medical Journal 2014; 37(1): 60 doi: 10.12771/emj.2014.37.1.60
|
53 |
Yonela Ntamo, Khanyisani Ziqubu, Nireshni Chellan, Bongani B. Nkambule, Tawanda M. Nyambuya, Sithandiwe E. Mazibuko-Mbeje, Kwazikwakhe B. Gabuza, Fabio Marcheggiani, Luca Tiano, Phiwayinkosi V. Dludla, Daniela Giustarini. Drug‐Induced Liver Injury: Clinical Evidence of N‐Acetyl Cysteine Protective Effects. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/3320325
|
54 |
José Castellote, Javier Ariza, Rosa Rota, Anna Girbau, Xavier Xiol. Serious drug-induced liver disease secondary to ezetimibe. World Journal of Gastroenterology 2008; 14(32): 5098-5099 doi: 10.3748/wjg.14.5098
|
55 |
|
56 |
Ning-Tao Wang, Yi-Shin Huang, Meng-Hsien Lin, Bryan Huang, Chin-Lin Perng, Han-Chieh Lin. Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: Systematic review and meta-analysis. Journal of the Chinese Medical Association 2016; 79(7): 368 doi: 10.1016/j.jcma.2015.12.006
|
57 |
Priscila A. de Faria, Fernanda Bettanin, Rodrigo L.O.R. Cunha, Edgar J. Paredes-Gamero, Paula Homem-de-Mello, Iseli L. Nantes, Tiago Rodrigues. Cytotoxicity of phenothiazine derivatives associated with mitochondrial dysfunction: A structure-activity investigation. Toxicology 2015; 330: 44 doi: 10.1016/j.tox.2015.02.004
|
58 |
Naresh Shanmugam, Anil Dhawan. Pediatric Hepatology and Liver Transplantation. 2019; : 145 doi: 10.1007/978-3-319-96400-3_8
|
59 |
PAULETTE BIOULAC-SAGE, CHARLES BALABAUD. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. 2009; : 1059 doi: 10.1016/B978-141604059-0.50043-6
|
60 |
Dennie GA Hebels, Marlon JA Jetten, Hugo JW Aerts, Ralf Herwig, Daniël HJ Theunissen, Stan Gaj, Joost H van Delft, Jos CS Kleinjans. Evaluation of Database-Derived Pathway Development for Enabling Biomarker Discovery for Hepatotoxicity. Biomarkers in Medicine 2014; 8(2): 185 doi: 10.2217/bmm.13.154
|
61 |
Erica L. Baker, Theodore Loewenthal, Edward Salerno, William L. Baker. Probable enoxaparin-induced hepatotoxicity. American Journal of Health-System Pharmacy 2009; 66(7): 638 doi: 10.2146/ajhp080311
|
62 |
Xuchen Zhang, Jie Ouyang, Swan N. Thung. Histopathologic Manifestations of Drug-induced Hepatotoxicity. Clinics in Liver Disease 2013; 17(4): 547 doi: 10.1016/j.cld.2013.07.004
|
63 |
Endalamaw Tesfa, Daniel Siefu, Yididya Belayneh, Zewdie Mekonnen. Liver enzyme elevation in patients taking HAART compared with treatment naïve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia. BMC Research Notes 2019; 12(1) doi: 10.1186/s13104-019-4748-4
|
64 |
Rolf Teschke, Alexander Genthner, Albrecht Wolff, Christian Frenzel, Johannes Schulze, Axel Eickhoff. Herbal hepatotoxicity: Analysis of cases with initially reported positive re-exposure tests. Digestive and Liver Disease 2014; 46(3): 264 doi: 10.1016/j.dld.2013.10.020
|
65 |
Raúl J Andrade, Susana López-Ortega, Mª Carmen López-Vega, Mercedes Robles, Ignacio Cueto, Mª Isabel Lucena. Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Review of Clinical Pharmacology 2008; 1(2): 261 doi: 10.1586/17512433.1.2.261
|
66 |
Miren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, Aida Ortega-Alonso, M. Isabel Lucena, Raúl J. Andrade. Drug induced liver injury: an update. Archives of Toxicology 2020; 94(10): 3381 doi: 10.1007/s00204-020-02885-1
|
67 |
M. V. Sargsyan, A. O. Melikyan, O. A. Melikyan. Hepatorenal and renocardial syndrome in young patients with acute glomerulonephritis. Experimental and Clinical Gastroenterology 2023; (8): 86 doi: 10.31146/1682-8658-ecg-216-8-86-92
|
68 |
Gail B. Mahady, Tieraona Low Dog, Marilyn L. Barrett, Mary L. Chavez, Paula Gardiner, Richard Ko, Robin J. Marles, Linda S. Pellicore, Gabriel I. Giancaspro, Dandapantula N. Sarma. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15(4): 628 doi: 10.1097/gme.0b013e31816054bf
|
69 |
A. Licata, V. Calvaruso, M. Cappello, A. Craxì, P.L. Almasio. Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication. Digestive and Liver Disease 2010; 42(2): 143 doi: 10.1016/j.dld.2009.06.009
|
70 |
Chi-Un Pae. Antipsychotics and Abnormal Liver Function Tests. Clinical Neuropharmacology 2012; 35(6): 297 doi: 10.1097/WNF.0b013e318278feeb
|
71 |
Fabio Firenzuoli, Luigi Gori, Paolo Roberti di Sarsina. Black Cohosh Hepatic Safety: Follow-Up of 107 Patients Consuming a SpecialCimicifuga racemosa rhizomeHerbal Extract and Review of Literature. Evidence-Based Complementary and Alternative Medicine 2011; 2011: 1 doi: 10.1093/ecam/nen009
|
72 |
Lama H. Nazer, Hisham M. Nazer. Textbook of Clinical Pediatrics. 2012; : 2113 doi: 10.1007/978-3-642-02202-9_219
|
73 |
S. Olivera-González, B. de Escalante-Yangüela, C. Velilla-Soriano, B. Amores-Arriaga, P. Martín-Fortea, M.E. Navarro-Aguilar. Hepatotoxicidad por metformina. Medicina Intensiva 2010; 34(7): 483 doi: 10.1016/j.medin.2009.10.006
|
74 |
Paresh Jobanputra, Roshan Amarasena, Fiona Maggs, Dawn Homer, Simon Bowman, Elizabeth Rankin, Andrew Filer, Karim Raza, Ronald Jubb. Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events. BMC Musculoskeletal Disorders 2008; 9(1) doi: 10.1186/1471-2474-9-48
|
75 |
E. Ocete Hita, J.A. Martín García, F. Giménez Sánchez, J.C. Flores González, A. Abril Molina, J. Salmerón Escobar, A. Ruiz Extremera. Hepatotoxicidad por fármacos o productos naturales en niños. Anales de Pediatría 2013; 78(4): 248 doi: 10.1016/j.anpedi.2012.06.012
|
76 |
Hassan Farghali, Mighty Kgalalelo Kemelo, Nikolina Kutinová Canová. SIRT1 Modulators in Experimentally Induced Liver Injury. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/8765954
|
77 |
Gerd A Kullak-Ublick, Raul J Andrade, Michael Merz, Peter End, Andreas Benesic, Alexander L Gerbes, Guruprasad P Aithal. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut 2017; 66(6): 1154 doi: 10.1136/gutjnl-2016-313369
|
78 |
Lamiaa A. Khatab, Ihab T. Abdel-Raheem, Asser I. Ghoneim. Protective effects of melatonin and l-carnitine against methotrexate-induced toxicity in isolated rat hepatocytes. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(1): 87 doi: 10.1007/s00210-021-02176-1
|
79 |
Daniel S. García, Etel I. Saturansky, Daniel Poncino, Yamila Martínez-Artola, Silvia Rosenberg, Gloria Abritta, Carlos Ascimani-Peña, Amerys Cravero. “Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?”. Annals of Hepatology 2019; 18(5): 765 doi: 10.1016/j.aohep.2019.01.011
|
80 |
Qin Sun, Qing Zhang, Jin Gu, Wen-wen Sun, Peng Wang, Chong Bai, He-ping Xiao, Wei Sha. Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study. Pharmacoepidemiology and Drug Safety 2016; 25(8): 908 doi: 10.1002/pds.3988
|
81 |
Milena M. Miljkovic, Silva Dobric, Viktorija Dragojevic‐Simic. Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity. Pharmacoepidemiology and Drug Safety 2011; 20(3): 272 doi: 10.1002/pds.2081
|
82 |
Cristina Lucía Dávila-Fajardo, Jesse J Swen, José Cabeza Barrera, Henk-Jan Guchelaar. Genetic Risk Factors for Drug-Induced Liver Injury in Rheumatoid Arthritis Patients Using Low-Dose Methotrexate. Pharmacogenomics 2013; 14(1): 63 doi: 10.2217/pgs.12.183
|
83 |
Donna L Mendrick, Kellye K Daniels. Biomarkers of drug-induced adverse events. Expert Review of Clinical Pharmacology 2008; 1(1): 81 doi: 10.1586/17512433.1.1.81
|
84 |
Brandy Garzel, Lei Zhang, Shiew-Mei Huang, Hongbing Wang. A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis. Current Drug Metabolism 2019; 20(8): 621 doi: 10.2174/1389200220666190709170256
|
85 |
Minyoung Her, YounJae Lee, EunUk Jung, TaeHee Kim, Dongyook Kim. Liver enzyme abnormalities in systemic lupus erythematosus: a focus on toxic hepatitis. Rheumatology International 2011; 31(1): 79 doi: 10.1007/s00296-009-1237-4
|
86 |
E.V. Perdices, M.I. Lucena, R.J. Andrade. Un caso de hepatopatía tóxica. Medicine - Programa de Formación Médica Continuada Acreditado 2012; 11(10): 624.e1 doi: 10.1016/S0304-5412(12)70358-X
|
87 |
Shibashish Giri, Karen Nieber, Augustinus Bader. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages. Expert Opinion on Drug Metabolism & Toxicology 2010; 6(8): 895 doi: 10.1517/17425251003792521
|
88 |
Mohammad Vikas Ashraf, Shreekar Pant, M. A. Hannan Khan, Ali Asghar Shah, Sazada Siddiqui, Mouna Jeridi, Heba Waheeb Saeed Alhamdi, Shoeb Ahmad. Phytochemicals as Antimicrobials: Prospecting Himalayan Medicinal Plants as Source of Alternate Medicine to Combat Antimicrobial Resistance. Pharmaceuticals 2023; 16(6): 881 doi: 10.3390/ph16060881
|
89 |
A. Chopra, M. Saluja, G. Tillu, S. Sarmukkaddam, A. Venugopalan, G. Narsimulu, R. Handa, V. Sumantran, A. Raut, L. Bichile, K. Joshi, B. Patwardhan. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology 2013; 52(8): 1408 doi: 10.1093/rheumatology/kes414
|
90 |
Adrian Reuben, David G. Koch, William M. Lee. Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study. Hepatology 2010; 52(6): 2065 doi: 10.1002/hep.23937
|
91 |
Marina Murillo-Villicaña, Ruth Noriega-Cisneros, Donovan J. Peña-Montes, Maribel Huerta-Cervantes, Asdrubal Aguilera-Méndez, Christian Cortés-Rojo, Rafael Salgado-Garciglia, Rocío Montoya-Pérez, Héctor Riveros-Rosas, Alfredo Saavedra-Molina. Antilipidemic and Hepatoprotective Effects of Ethanol Extract of Justicia spicigera in Streptozotocin Diabetic Rats. Nutrients 2022; 14(9): 1946 doi: 10.3390/nu14091946
|
92 |
Naresh P. Shanmugam, Chayarani Kelgeri, Anil Dhawan. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2016; : 831 doi: 10.1007/978-3-319-17169-2_70
|
93 |
Raúl J Andrade, M Isabel Lucena. Evidence‐Based Gastroenterology and Hepatology. 2010; : 771 doi: 10.1002/9781444314403.ch47
|
94 |
Todd Stedeford. Information Resources in Toxicology. 2009; : 423 doi: 10.1016/B978-0-12-373593-5.00047-1
|
95 |
Jesmin Mondal, Kausik Bishayee, Ashis Kumar Panigrahi, Anisur Rahman Khuda-Bukhsh. Low doses of ethanolic extract of Boldo (Peumus boldus) can ameliorate toxicity generated by cisplatin in normal liver cells of mice in vivo and in WRL-68 cells in vitro, but not in cancer cells in vivo or in vitro. Journal of Integrative Medicine 2014; 12(5): 425 doi: 10.1016/S2095-4964(14)60045-5
|
96 |
Udhaya Lavinya Baskaran, Evan Prince Sabina. Clinical and experimental research in antituberculosis drug-induced hepatotoxicity: a review. Journal of Integrative Medicine 2017; 15(1): 27 doi: 10.1016/S2095-4964(17)60319-4
|
97 |
Vijay Gayam, Amrendra Kumar Mandal, Mazin Khalid, Binav Shrestha, Pavani Garlapati, Mowyad Khalid. Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review. Journal of Community Hospital Internal Medicine Perspectives 2018; 8(5): 311 doi: 10.1080/20009666.2018.1514933
|
98 |
Sankhadip Bose, Rana Datta, Ward G. Kirlin. Evidence Based Validation of Traditional Medicines. 2021; : 621 doi: 10.1007/978-981-15-8127-4_30
|
99 |
Jingyu Lee, Myeong-Sang Yu, Dokyun Na. DILI-Stk: An Ensemble Model for the Prediction of Drug-induced Liver
Injury of Drug Candidates. Current Bioinformatics 2022; 17(3): 296 doi: 10.2174/1574893617666211228113939
|
100 |
Libo Wang, Xi Chen, Shijian Wang, Jing Wei, Jiabing Wang. Exploration of the clinical characteristics and potential mechanisms of liver injury induced by proton pump inhibitors. Expert Opinion on Drug Safety 2024; : 1 doi: 10.1080/14740338.2024.2418320
|
101 |
William Norris, Angelo H Paredes, James H Lewis. Drug-induced liver injury in 2007. Current Opinion in Gastroenterology 2008; 24(3): 287 doi: 10.1097/MOG.0b013e3282f9764b
|
102 |
E. I. Sas, V. B. Grinevich. Multi-component infusion hepatoprotectors for liver damage. Medical Council 2019; (3): 84 doi: 10.21518/2079-701X-2019-3-84-88
|
103 |
Naresh P. Shanmugam, Anil Dhawan. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2022; : 995 doi: 10.1007/978-3-030-80068-0_73
|
104 |
Deepthi Mary George, Princy Louis Palatty. Pattern of adverse drug reactions to anticancer drugs at an apex hospital in south India: A retrospective study. Indian Journal of Pharmacy and Pharmacology 2022; 9(3): 191 doi: 10.18231/j.ijpp.2022.034
|